Two-tiered GLP-1 market post-generics
The guest argued the obesity drug market will evolve into a two-tiered structure, with branded drugs like Eli Lilly's Mounjaro maintaining a premium position while generic semaglutide expands total volume in lower-income brackets.
Sign in to read the full idea
The argument, what validates it, the risks discussed and hearing it from the source are for signed-in members. Free accounts read 3 ideas in full a day. No card required.